| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | Oct 24, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 46.3 | -2,595 | -1.18% | ✗ | $49.4K |
| Oct 8, 2025 | Oct 10, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 48.8 | -1,272 | -0.57% | ✗ | $20.7K |
| Jul 23, 2025 | Jul 25, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 46.3 | -2,385 | -1.06% | ✗ | $43.3K |
| Jul 9, 2025 | Jul 11, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 48.8 | -1,160 | -0.51% | ✗ | $20K |
| Apr 23, 2025 | Apr 25, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 46.3 | -2,349 | -1.03% | ✗ | $34.7K |
| Apr 9, 2025 | Apr 11, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -6,169 | -2.64% | ✗ | $80.1K |
| Jan 22, 2025 | Jan 24, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -2,657 | -1.97% | ✗ | $62.7K |
| Oct 23, 2024 | Oct 25, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -3,189 | -2.31% | ✗ | $94.2K |
| Jul 24, 2024 | Jul 26, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -3,456 | -2.44% | ✗ | $95.9K |
| Apr 24, 2024 | Apr 26, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -3,261 | -2.25% | ✗ | $94.2K |
| Jan 26, 2024 | Jan 29, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 40.0 | -10,101 | -10.10% | ✗ | $383K |